Cellosaurus logo
expasy logo

Cellosaurus 1383D2 (CVCL_UP38)

[Text version]
Cell line name 1383D2
Synonyms HPS1005
Accession CVCL_UP38
Resource Identification Initiative To cite this cell line use: 1383D2 (RRID:CVCL_UP38)
Comments From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
Population: Asian.
Omics: Genome sequenced.
Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
HLA typing Source: PubMed=30853558
Class I
Class II
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Children:
CVCL_C1FK (1383D2-B2M-KO #1)CVCL_C1FL (1383D2-B2M-KO #2)
Originate from same individual CVCL_UP39 ! 1383D6
Sex of cell Male
Age at sampling 36Y
Category Induced pluripotent stem cell

PubMed=28453617; DOI=10.1093/biolre/iox038
Yokobayashi S., Okita K., Nakagawa M., Nakamura T., Yabuta Y., Yamamoto T., Saitou M.
Clonal variation of human induced pluripotent stem cells for induction into the germ cell fate.
Biol. Reprod. 96:1154-1166(2017)

PubMed=30853558; DOI=10.1016/j.stem.2019.02.005
Xu H.-G., Wang B., Ono M., Kagita A., Fujii K., Sasakawa N., Ueda T., Gee P., Nishikawa M., Nomura M., Kitaoka F., Takahashi T., Okita K., Yoshida Y., Kaneko S., Hotta A.
Targeted disruption of HLA genes via CRISPR-Cas9 generates iPSCs with enhanced immune compatibility.
Cell Stem Cell 24:566-578.e7(2019)

Hotta A., Xu H.-G., Kaneko S., Wang B.
Method for producing low-antigenic cell.
Patent number US20200407693, 31-Dec-2020

Cell line collections (Providers) RCB; HPS1005
Encyclopedic resources Wikidata; Q93298761
Entry history
Entry creation25-Feb-2019
Last entry update29-Jun-2023
Version number7